Composition

Each CLAVINEX DUO tablet contains:
Amoxicillin (as trihydrate) 875 mg
Clavulanic acid (as potassium clavulanate) 125 mg
Excipients q.s.

Each 5 ml of CLAVINEX DUO recontituted suspension contains:
Amoxicillin (as trihydrate) 400 mg
Clavulanic acid (as potassium clavulanate) 57 mg
Excipients q.s.

Each 5 ml of CLAVINEX DUO FORTE reconstituted suspension contains:
Amoxicillin (as trihydrate) 800 mg
Clavulanic acid (as potassium clavulanate) 57 mg
Excipients q.s.

Indications

Treatment of infections of the upper and lower respiratory tract, urinary tract, skin and soft tissue, intraabdomianl sepsis, osteomyelitis, caused by sensitive microorganisms y beta-lactamase producers supported by an antibiogram.

Used in infections caused by microorganisms sensitive to Amoxicillin and infections caused by microorganisms sensitive to Amoxicillin and beta-lactamase producers such as:

• Infections of the upper respiratory tract: e.g.: tonsillitis, sinusitis, and otitis media.
• Infections of the lower respiratory tract: e.g.: acute chronic bronchitis with exacerbations, bronchopneumonia.
• Infections of the genitourinary tract: cystitis, urethritis, pyelonephritis, female genital infections.
• Skin and soft tissue infections.
• Bone and joint infections: e.g. osteomyelitis
• Other infections: e.g.: septic abortion, puerperal sepsis, intraabdominal sepsis, septicemia, peritonitis, post-operative infections.
• Prophylaxis against infections associated with major surgical procedures such as gastrointestinal, pelvis, head and neck, heart, kidney, bone replacement, and biliary tract surgeries.